Systematic Review of the Delivery of Mydriacyl to the Inpatient Pediatric Floors at LVHN for an Ophthalmology Consultation. by Barron, Christopher
Lehigh Valley Health Network
LVHN Scholarly Works
USF-LVHN SELECT
Systematic Review of the Delivery of Mydriacyl to
the Inpatient Pediatric Floors at LVHN for an
Ophthalmology Consultation.
Christopher Barron
USF MCOM- LVHN Campus, Christopher.Barron@lvhn.org
Follow this and additional works at: http://scholarlyworks.lvhn.org/select-program
Part of the Medical Education Commons
This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an
authorized administrator. For more information, please contact LibraryServices@lvhn.org.
Published In/Presented At
Barron, C. (2017, March). Systematic Review of the Delivery of Mydriacyl to the Inpatient Pediatric Floors at LVHN for an Ophthalmology






After detailing the medication delivery 
process of the ophthalmic drug, 
Tropicamide, to the Pediatrics Floor at 
the Lehigh Valley Health Network, this 
study aims to identify where and how 
the process might fail and to assess the 
relative impact of different failures, in 
order to identify the parts of the process 
that are most in need of change.  
For a hospital to operate within its 
budget, it must offer efficient and 
expedient services.  In order to provide 
quality, yet affordable care, a hospital 
must be efficient in its practices.   It 
must provide the right treatment, at the 
right time because there is an associated 
opportunity costs with diagnosis and 
treatment errors and delays (failure 
modalities).  Medication delivery is an 
integral system to a well-functioning 
hospital—it must be quick and most 
importantly, correct.   
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Problem Statement
Using the Institute of Healthcare Improvement (IHI) Failure Modalities and Effects Analysis, 
this cross sectional study interviewed and surveyed teams and individuals to answer three 
questions: what could go wrong? Why would the failure happen? and What would be the 
consequences of each failure?  Interviewees of representative of pharmacy and pediatric 
nursing assigned numbers (1-10) for each of the questions asked, and a Risk Priority Number 
(RPN) was calculated for each failure modality which is used to prioritize the modality that 
needs to be assessed first, and with the most priority.  The results, for the pharmacy and 
nursing teams are listed below.  The higher the RPN, the potentially more serious the failure 
modality, and should be addressed first.
Results
 
Of note, both pharmacy and nursing teams made suggestions that the delivery process of 
tropicamide could be improved by permanently keeping tropicamide stocked in the Pyxis 
units on the floors, and ultimately creating a stand alone pediatric pharmacy that is separate 
from the main hospital pharmacy.  With regards to Pyxis, both teams felt that there was 
enough free space in the device that could store the tropicamide drops.  They felt that this 
would ensure a quicker, and more efficient delivery process, by bypassing the pharmacy 
collection and distribution process.  Additionally, both units felt that to minimize any potential 
errors to the pediatrics floors, a pediatric stand alone pharmacy should be created.  This 
would allow for a reduction of errors and an decrease in transit time because it would be 
streamlined for pediatric, not adult patient, needs.
Discussion
 
THE IHI FMEA tool per nursing and pharmacy teams identified several failure modalities and 
the RPNs associated with each modality.  Misplacing Tropicamide was calculated to have 
the highest RPN for both sub groups.  Upon further questioning, both pharmacy and nursing 
stated that it is the most likely to occur of all of the modalities and that it is the hardest 
to detect (ie find the misplaced drops).  This in turn can related to delay in delivery of the 
dilating drops which is a delay in patient care.  It also represents an opportunity cost to the 
consultant.  Moroever, this project also provided suggestions on how to improve the process, 
most notably, consider stocking tropicamide in the Pyxis units on the floors.
Conclusions
Failure Modalities and Occurence, Detection, Severity & RPN 
for Tropicamide Delivery Process per Nursing Team
                Occurrence Detection Severity RPN
Misplaced 5 8 6 240
Delivered to Wrong Pt 2 10 10 200
Wrong Dose 5 3 4 60
Time Delay 6 1 6 36
Wrong Drug 3 1 5 15
Failure Modalities and Occurence, Detection, Severity & RPN 
for Tropicamide Delivery Process per Pharmacy Team
                Occurrence Detection Severity RPN
Misplaced 2 6 7 84
Time Delay 1 5 5 25
Delivered to Wrong Pt 1 2 9 18
Wrong Drug 1 2 8 16
Wrong Dose 1 2 6 12
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